123, they wouldn't have to recoup the monies if they staged payment, an easy way around it all, that's even if it was about that.
As far as your continued reference to the Bioshares article, it states exactly:
If the company can secure a licensing deal by August, then it anticipates a product launch in Europe by years end.
